Actively Recruiting
Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours
Led by IRCCS San Raffaele · Updated on 2025-05-01
70
Participants Needed
1
Research Sites
306 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this prospective observational study is to generate new personalised 3D preclinical models of pancreatic neuroendocrine tumors. The models will be exploited for studying the mechanisms underlying disease development and progression, as well as for performing drug testing. For the development of the newly proposed models, patients' surgical specimens will be evaluated by the Pathological Unit. If the presence of pathological material in excess, not required for the routine diagnostic procedure, is confirmed, such material will be employed for the generation of the proposed personalised models.
CONDITIONS
Official Title
Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who undergo pancreatic surgical resection for non-functioning pancreatic neuroendocrine tumor
- Age 18 years or older
- Informed consent
You will not qualify if you...
- Diagnosis of non-pancreatic neuroendocrine tumor
- Age under 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS San Raffele Institute
Milan, MI, Italy, 20132
Actively Recruiting
Research Team
M
Massimo Falconi, Professor
CONTACT
A
Anna Battistella, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here